Table 1 Patients’ MRI criteria
From: Relation between morphological features of initial breast MRI and breast cancer molecular subtypes
Parameters | Number | Percent |
|---|---|---|
Multicentricity | ||
Unicentric | 11 | 36.7 |
Multicentric | 19 | 63.3 |
Tumor size (MRI)1 | ||
T1 | 2 | 6.7 |
T2 | 16 | 53.3 |
T3 | 4 | 13.3 |
T4 | 8 | 26.7 |
Lymph nodes (MRI) | ||
Positive | 25 | 83.3 |
Negative | 5 | 16.7 |
Lesion site | ||
Upper quadrant | 20 | 66.7 |
Lower quadrant | 14 | 46.7 |
Central | 12 | 40 |
Contralateral breast lesion (MRI)4 | 4 | 13.3 |
Benign lesions in MRI5 | 5 | 16.7 |
Mass shape | ||
Round | 15 | 50 |
Oval | 2 | 6.7 |
Irregular | 12 | 40 |
Non-mass enhancement | 1 | 3.3 |
Mass margin | ||
Speculated | 19 | 63.3 |
Irregular | 8 | 26.7 |
Angulated | 2 | 6.7 |
Well-defined | 1 | 3.3 |
Curve types | ||
Type 1 | 1 | 3.3 |
Type 2 | 20 | 66.7 |
Type 3 | 9 | 30 |